http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9922022-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f47b7702d365521bd298d7f4c7b9971e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
filingDate 1998-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7b5ad7ba389aee28bd4f35fb14c99d4
publicationDate 1999-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9922022-A2
titleOfInvention Test procedure for identifying persons with defective mismatch repair systems
abstract The invention relates to a test procedure to establish the existence of a hereditary defect in the mismatch repair system (MMR system) or to establish the existence of hereditary non-polyposis colorectal cancer (HNPCC) or a predisposition thereto in a person to be examined. The inventive test procedure involves the culturing of non-neoplastic cells of the person to be examined in conditions permitting cell division, whereby a mutagenic stimulus is provided before and/or during culturing. The invention also includes the production of several DNA samples from the cultivated cells which correspond basically to one or several of these cells with respect to DNA quantity or genomic DNA sequential information contained therein. The information finally includes the amplification of certain sections of the DNA samples by means of polymerase chain reaction (PCR) using sequence-specific primers, especially microsatellite DNA specific primers, and the analysis of amplification products in relation to a higher occurrence of mutations within the amplified sequences. Another aspect of the invention is related to the use of microsatellite DNA specific primers in the inventive method.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10214788-A1
priorityDate 1997-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9515381-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9516793-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19712332-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128509153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396023
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127822793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941

Total number of triples: 29.